BRD9 status is a major contributor for cysteine metabolic remodeling through MST and EAAT3 modulation in malignant melanoma.
Hipólito A, Xavier R, Brito C, Tomás A, Lemos I, Cabaço LC, Silva F, Oliva A, Barral DC, Vicente JB, Gonçalves LG, Pojo M, Serpa J.
Hipólito A, et al. Among authors: barral dc.
Biochim Biophys Acta Mol Basis Dis. 2024 Feb;1870(2):166983. doi: 10.1016/j.bbadis.2023.166983. Epub 2023 Dec 7.
Biochim Biophys Acta Mol Basis Dis. 2024.
PMID: 38070581
Free article.